Auna 3Q26: Revenue Up 19% to S/1,325M, Adjusted EBITDA Flat at S/231M; Colombia Contract Terminated
AUNA is trading near its 52-week low of $4.09 (13% above the low).
Summary
Auna's 3Q26 revenue rose 19% to S/1,325 million but Adjusted EBITDA was flat at S/231 million as Colombia margins collapsed 30% in local currency; the company terminated the problem oncology contract and leverage improved to 3.5x.
Key Events · Earnings and Guidance · AUNA
-
3Q26 Revenue Grows, EBITDA Flat
Revenue rose 19% as reported and 10% FX-neutral to S/1,325 million, while Adjusted EBITDA was S/231 million, flat as reported and down 4.6% FX-neutral; the margin fell to 17.5% from 18.4% in 2Q26.
-
Colombia Oncology Contract Terminated
Colombia Segment Adjusted EBITDA fell 30% in local currency on adverse medical costs under an oncology risk-sharing contract covering about 500,000 lives and roughly 4% of Colombia revenue; Auna terminated the contract after the quarter and engaged legal counsel to review recovery options.
-
Mexico Returns to EBITDA Growth
Mexico Segment Adjusted EBITDA rose 5% year over year in local currency, its first such growth in 2026, on higher surgery and oncology volumes at the Monterrey network.
-
Cash Flow Up, Leverage at 3.5x
Year-to-date net cash from operating activities rose 62% to S/713 million and free cash flow 95% to S/626 million; net debt fell to S/3,133 million from S/3,321 million at December 2025, cutting leverage to 3.5x from 3.6x.
Analysis · AUNA · Industrial Applications And Services
Revenue rose 19% as reported to S/1,325 million, yet Adjusted EBITDA was flat at S/231 million and down 4.6% FX-neutral, with the margin slipping to 17.5% from 18.4% in 2Q26. The profit hit is concentrated in Colombia, where Segment Adjusted EBITDA fell 30% in local currency after an oncology risk-sharing contract covering about 500,000 lives produced medical costs far above contractual assumptions; Auna has terminated that contract, which was roughly 4% of Colombia's revenue, and hired legal counsel to pursue recovery. Mexico finally turned positive, with Segment Adjusted EBITDA up 5% year over year in local currency. Cash generation is the offset: year-to-date operating cash flow rose 62% to S/713 million and free cash flow 95% to S/626 million, pulling leverage down to 3.5x from 3.6x. Net income fell to S/24 million from S/53 million, largely because a S/40 million non-cash FX gain in 3Q25 did not repeat.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AUNA was trading at $4.61 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $353M. The 52-week trading range was $4.09 to $6.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.